Technical Analysis for APLI - Appili Therapeutics Inc

Grade Last Price % Change Price Change
C 0.040 14.29% 0.005
APLI closed up 14.29 percent on Tuesday, April 16, 2024, on approximately normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Flat Up Down

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Hammer Candlestick Bullish 0.00%
Lizard Bullish Bullish Day Trade Setup 0.00%
Doji - Bullish? Reversal 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Fell Below 20 DMA Bearish 14.29%
Fell Below 200 DMA Bearish 14.29%
MACD Bearish Signal Line Cross Bearish 14.29%
Volume Surge Other 14.29%

   Recent Intraday Alerts

Alert Time
Gap Up Closed about 19 hours ago
20 DMA Support about 19 hours ago
Possible NR7 about 20 hours ago
Gapped Up (Full) 1 day ago
Rose Above 20 DMA 1 day ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Appili Therapeutics Inc Description

Appili Therapeutics Inc is a Canada-based anti-infective pharmaceutical development company. The Company focuses on identifying, acquiring and advancing therapeutics for infectious disease. The Company is engaged in developing strategies to develop new classes of antibiotics and anti-infectives to the clinic to improve treatment and health of patients suffering from infection. The Company has over two anti-infective programs, which include ATI-1501 and ATI-1503. The Company's ATI-1501 is a taste-masked treatment for clostridium difficile infection. The Company's ATI-1503 is an antibiotic with a potential to treat Gram-negative infections, such as Klebsiella pneumoniae. The Company’s agents focus on the therapeutics, including antivirals, antifungals, antiparasitics and antimicrobials, which can treat the hospital and community acquired infections caused by multi-drug resistant pathogens.


Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharma Pharmaceutical Clinic Drug Disease Bacteria Infection Antibiotic Antimicrobial Anti Infectives Antibiotics Organisms Antivirals Biocides Infections Infectious Disease

Is APLI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 0.08
52 Week Low 0.025
Average Volume 243,264
200-Day Moving Average 0.040
50-Day Moving Average 0.033
20-Day Moving Average 0.039
10-Day Moving Average 0.044
Average True Range 0.005
RSI (14) 54.13
ADX 13.96
+DI 28.750
-DI 33.472
Chandelier Exit (Long, 3 ATRs) 0.045
Chandelier Exit (Short, 3 ATRs) 0.040
Upper Bollinger Bands 0.052
Lower Bollinger Band 0.025
Percent B (%b) 0.55
BandWidth 69.430
MACD Line 0.003
MACD Signal Line 0.003
MACD Histogram -0.0004
Fundamentals Value
Market Cap 2.49 Million
Num Shares 62.3 Million
EPS -0.15
Price-to-Earnings (P/E) Ratio -0.26
Price-to-Sales 280.78
Price-to-Book 3.58
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.048
Resistance 3 (R3) 0.047 0.043 0.046
Resistance 2 (R2) 0.043 0.041 0.044 0.046
Resistance 1 (R1) 0.042 0.040 0.043 0.043 0.045
Pivot Point 0.038 0.038 0.039 0.039 0.038
Support 1 (S1) 0.037 0.036 0.038 0.038 0.035
Support 2 (S2) 0.033 0.035 0.034 0.034
Support 3 (S3) 0.032 0.033 0.034
Support 4 (S4) 0.033